Cipla Launches Generic Pomalidomide Capsules in the US
Cipla continues to expand its generic portfolio in the US with the launch of pomalidomide capsules for the treatment of adult patients with multiple myeloma.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Cipla continues to expand its generic portfolio in the US with the launch of pomalidomide capsules for the treatment of adult patients with multiple myeloma.
Patients and healthcare providers are advised not to use any DARZALEX products bearing batch numbers MYS7381 or STV1K01.
Johnson & Johnson said the CHMP opinion is an important step towards positioning the off-the-shelf immunotherapy combination of teclistamab and daratumumab as a potential new standard of care earlier in the multiple myeloma treatment pathway.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.


